logo

For the Inventor, By the Inventor

Stevenage, United Kingdom

Autifony Therapeutics Limited


USPTO Granted Patents = 25

% Expired Patents = 8.0



Forward Citations = 82

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Giuseppe Alvaro (22 out of 58 patents)

silverMedal Agostino Marasco (21 out of 28 patents)

bronzeMedal Charles Large (10 out of 12 patents)

4.  Dieter Hamprecht (10 out of 24 patents)

5.  Anne Decor (8 out of 18 patents)

6.  Paolo Dambruoso (7 out of 10 patents)

7.  Simona Tommasi (7 out of 8 patents)

8.  Stefano Fontana (5 out of 6 patents)

9.  Anne Dècor (4 out of 4 patents)

10.  Giuseppe Alvaro (2 out of 2 patents)

11.  Guido Marconi (1 out of 1 patent)

12.  Anne Décor (1 out of 1 patent)

13.  Charles Large (1 out of 1 patent)

14.  Agostino Marasco (1 out of 1 patent)

15.  Anne Decor (0 patent)


Core Competencies:
KV3 Modulators
Pain Treatment
Hydantoin Derivatives
Kv3 Inhibitors
Imidazolidinedione Derivatives
Triazoles
Compounds
Channel Modulation
Pharmaceuticals
Pain Management

25 patents:

1. 12358901 - KV3 modulators (2025-07-15),
2. 11944623 - Modulators of Kv3 channels to treat pain (2024-04-02),
3. 11583527 - Hydantoin derivatives useful as Kv3 inhibitors (2023-02-21),
4. 11541052 - Compounds (2023-01-03),
5. 11197859 - Hydantoin derivatives useful as Kv3 inhibitors (2021-12-14),
6. 11180461 - Triazoles as Kv3 inhibitors (2021-11-23),
7. 11147813 - Modulators of KV3 channels to treat pain (2021-10-19),
8. 10934278 - Compounds (2021-03-02),
9. 10835534 - Compounds (2020-11-17),
10. 10632118 - Imidazolidinedione derivatives (2020-04-28),
11. 10611735 - Triazoles as Kv3 inhibitors (2020-04-07),
12. 10555945 - Compounds (2020-02-11),
13. 10160730 - Triazoles as KV3 inhibitors (2018-12-25),
14. 10098881 - Compounds (2018-10-16),
15. 10058551 - Imidazolidinedione derivatives (2018-08-28),
Company Overview
Autifony Therapeutics Limited is a biopharmaceutical company based in Stevenage, UK, focused on developing innovative treatments for hearing disorders. The company specializes in the research and development of novel therapeutics that target the underlying mechanisms of auditory processing and related conditions. By leveraging advanced scientific insights and technologies, Autifony aims to address unmet medical needs in the field of audiology, enhancing the quality of life for individuals affected by hearing impairments.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Autifony Therapeutics Limited USPTO Patent Assignee Logo
25 Patents

#3 in Stevenage

#703 in United Kingdom

#25,730 in the World

Stevenage, GB
Stevenage, United Kingdom

Autifony Therapeutics Limited

Forward Citations = 82

14 inventors:

goldMedal Giuseppe Alvaro (22 out of 58 patents)

silverMedal Agostino Marasco (21 out of 28 patents)

bronzeMedal Charles Large (10 out of 12 patents)

4.  Dieter Hamprecht (10 out of 24 patents)

5.  Anne Decor (8 out of 18 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Autifony Therapeutics Limited. Retrieved from https://idiyas.com/company/autifony-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…